Back to search
Cholestasis in Newborn
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Cholestasis in Newborn trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Cholestasis in Newborn trials you may qualify forThe purpose of this study is to create a national, multi-centre registry for children with Alagille syndrome (ALGS) and Genetic Intrahepatic Cholestasis (GIC) t…
The purpose of this study is to assess the long-term safety and effectiveness of odevixibat in participants with Alagille syndrome (ALGS). The participants of…
This study will collect information from patients with Alagille syndrome (ALGS) as they use odevixibat (Bylvay) in their daily lives. Odevixibat is a medicine…
This study is a database study in Japan for maralixibat (TAK-625) used to treat participants with Alagille Syndrome (ALGS) and Progressive Familial Intrahepatic…
In infants that present with findings concerning for biliary atresia, along with other cholestatic work up which is standard, they will receive a one-time intra…
The key objectives of this low-intervention clinical study are to evaluate tolerability, long-term safety and long-term efficacy for patients with Alagille synd…
The goal of this clinical trial is to determine the prevalence of exocrine pancreatic insufficiency (EPI) in a population of pediatric and adult participants wi…
To observe the efficacy and safety of atorvastatin on xanthoma in Alagille syndrome through a prospective study.
Biliary atresia (BA) is a neonatal liver disease characterized by impaired bile flow and is the most common indication for pediatric liver transplantation. BA c…